CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk

Blood

Volumn 97, Issue 9, 2001, Pages 2633-2639

  Oda, Atsushi ^a,b,c,d,e   Ochs, Hans D ^a,b,c,d   Lasky, Laurence A ^a,b,c,d   Spencer, Susan ^a,b,c,d   Ozaki, Katsutoshi ^a,b,c,d   Fujihara, Mitsuhiro ^a,b,c,d   Handa, Makoto ^a,b,c,d   Ikebuchi, Kenji ^a,b,c,d   Ikeda, Hisami ^a,b,c,d  

^a Japanese Red Cross Society   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d GENENTECH INC   (United States)

^e HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; COLLAGEN; CRK LIKE PROTEIN; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; PAXILLIN; PROTEIN; PROTEIN HIC 5; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; WISKOTT ALDRICH SYNDROME PROTEIN;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; CROSS LINKING; CYTOSKELETON; ENDOSOME; GENE MUTATION; HUMAN; HUMAN CELL; PODOSOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; WISKOTT ALDRICH SYNDROME; X CHROMOSOME LINKAGE;

EID: 0035353161     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.9.2633     Document Type: Article

References (47)

1. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 1994;78:635-644.
2. Villa A, Notarangelo L, Macchi P. X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet. 1995;9:414-417.
3. Zhu Q, Zhang M, Blaese RM, et al. The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene. Blood. 1995;86:3797-3804.
4. Snapper SB, Rosen FS. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization. Annu Rev Immunol. 1999;17:905-929.
5. Thrasher AJ, Jones GE, Kinnon C, Brickell PM, Katz DR. Is Wiskott-Aldrich syndrome a cell trafficking disorder? Immunol Today. 1998;19:537-539.
6. Ramesh N, Anton IM, Martinez-Quiles N, Geha RS. Waltzing with WASP. Trends Cell Biol. 1999;9:15.
7. Machesky LM, Insall RH. Scar1 and the related Wiskott-Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex. Curr Biol. 1998;8:1347-1356.
8. Higgs HN, Blanchoin L, Pollard TD. Influence of the C terminus of Wiskott-Aldrich syndrome protein (WASp) and the Arp2/3 complex on actin polymerization. Biochemistry. 1999;38:15212-15222.
9. Aspenstrom P, Lindberg U, Hall A. Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome. Curr Biol. 1996;6:70-75.
10. Symons M, Derry JM, Karlak B, et al. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell. 1996;84:723-734.
11. Linder S, Nelson D, Weiss M, Aepfelbacher M. Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc Natl Acad Sci U S A. 1999;96:9648-9653.
12. Suzuki T, Shoji S, Yamamoto K, et al. Essential roles of Lyn in fibronectin-mediated filamentous actin assembly and cell motility in mast cells. J Immunol. 1998;161:3694-3701.
13. DeFife KM, Jenney CR, Colton E, Anderson JM. Cytoskeletal and adhesive structural polarizations accompany IL-13-induced human macrophage fusion. J Histochem Cytochem. 1999;47:65-74.
14. Salgia R, Uemura N, Okuda K, et al. CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells. J Biol Chem. 1995;270:29145-29150.
15. Oda A, Miyakawa Y, Druker BJ, et al. Crkl is constitutively tyrosine phosphorylated in platelets from chronic myelogenous leukemia patients and inducibly phosphorylated in normal platelets stimulated by thrombopoietin. Blood. 1996;88:4304-4313.
16. Ozaki K, Oda A, Wakao H, et al. Thrombopoietin induces association of Crkl with STAT5 but not STAT3 in human platelets. Blood. 1998;92:4652-4662.
17. Oda A, Ochs HID, Druker BJ, et al. Collagen induces tyrosine phosphorylation of Wiskott-Aldrich syndrome protein in human platelets, Blood. 1998;92:1852-1858.
18. Gross BS, Wilde JI, Quek L, et al. Regulation and function of WASP in platelets by the collagen receptor, glycoprotein VI. Blood. 1999;94:4166-4176.
19. Oda A, Ikeda Y, Ochs HD, et al. Rapid tyrosine phosphorylation and activation of Btk/Tec kinases in platelets induced by collagen binding or CD32 cross-linking. Blood. 2000;95:1663-1670,
20. Guinamard R, Aspenstrom P, Fougereau M, Chavrier P, Guillemot JC. Tyrosine phosphorylation of the Wiskott-Aldrich syndrome protein by Lyn and Btk is regulated by CDC42. FEBS Lett. 1998;434:431-436.
21. Baba Y, Nonoyama S, Matsushita M, et al. Involvement of Wiskott-Aldrich syndrome protein in B-cell cytoplasmic tyrosine kinase pathway. Blood. 1999;93:2003-2012.
22. Poole A, Gibbins JM, Turner M, et al. The Fc receptor γ-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J. 1997;16:2333-2341.
23. Heaney C, Kolibaba K, Bhat A, et al. Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation. Blood. 1997;89:297-306.
24. Wu Y, Spencer SD, Lasky LA. Tyrosine phosphorylation regulates the SH3-mediated binding of the Wiskott-Aldrich syndrome protein to PSTPIP, a cytoskeletal-associated protein. J Biol Chem. 1998;273:5765-5770.
25. Oda A, Ozaki K, Druker BJ, et al. p120c-cbl is present in human blood platelets and is differentially involved in signaling by thrombopoietin and thrombin. Blood. 1996;88:1330-1338.
26. Polgar J, Clemetson JM, Kehrel BE, et al. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. J Biol Chem. 1997;272:13576-13583.
27. Saci A, Pain S, Rendu F, Bachelot-Loza C. Fc receptor-mediated platelet activation is dependent on phosphatidylinositol 3-kinase activation and involves p120(Cbl). J Biol Chem. 1999;274:1898-1904.
28. ten Hoeve J, Kaartinen V, Fioretos T, et al. Cellular interactions of CRKL, and SH2-SH3 adaptor protein. Cancer Res. 1994;54:2563-2567.
29. Sattler M, Salgia R. Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells. Leukemia. 1998;12:637-644.
30. Feller SM, Posern G, Voss J, et al. Physiological signals and oncogenesis mediated through Crk family adapter proteins. J Cell Physiol. 1988;177:535-352.
31. 2+ mobilization in platelets. J Biol Chem. 1993;268:2277-2279.
32. Tohyama Y, Yanagi S, Sada K, Yamamura H. Translocation of p72syk to the cytoskeleton in thrombin-stimulated platelets. J Biol Chem. 1994;269:32796-32799.
33. Hagmann J, Grob M, Welman A, van Willigen G, Burger MM. Recruitment of the LIM protein hic-5 to focal contacts of human platelets. J Cell Sci. 1998;111:2181-2188.
34. Lorenzi R, Brickell PM, Katz DR, Kinnon C, Thrasher AJ. Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis. Blood. 2000;95:2943-2946.
35. May RC, Caron E, Hall A, Machesky LM. Involvement of the Arp2/3 complex in phagocytosis mediated by FcγR or CR3. Nat Cell Biol. 2000;2:246-248.
36. Arai A, Nosaka Y, Kohsaka H, Miyasaka N, Miura O. CrkL activates integrin-mediated hematopoietic cell adhesion through the guanine nucleotide exchange factor C3G. Blood. 1999;93:3713-3722.
37. Uemura N, Griffin JD. The adapter protein crkl links cbl to C3G after integrin ligation and enhances cell migration. J Biol Chem. 1999;274:37525-37532.
38. Nore BF, Vargas L, Mohamed AJ, et al. Redistribution of Bruton's tyrosine kinase by activation of phosphatidylinositol 3-kinase and rho-family GT-Pases. Eur J Immunol. 2000;30:145-154.
39. Ohmori T, Yatomi Y, Asazuma N, Satoh K, Ozaki Y. Suppression of protein kinase C is associated with inhibition of PYK2 tyrosine phosphorylation and enhancement of PYK2 interaction with Src in thrombin-activated platelets. Thromb Res. 1999;93:291-298.
40. Rivero-Lezcano OM, Marcilla A, Sameshima JH, Robbins KC. Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains. Mol Cell Biol. 1995;15:5725-5731.
41. Oda A, Sawada K, Druker BJ, et al. Erythropoietin induces tyrosine phosphorylation of Jak2, STAT5A, and STAT5B in primary cultured human erythrold precursors. Blood. 1998;92:443-451.
42. Fish EN, Uddin S, Korkmaz M, Majchrzak B, Druker BJ, Platanias LC. Activation of a CrkL-stat5 signaling complex by type I interferons. J Biol Chem. 1999;274:571-573.
43. Gelkop S, Isakov N. T cell activation stimulates the association of enzymatically active tyrosine-phosphorylated ZAP-70 with the Crk adapter proteins. J Biol Chem. 1999;274:21519-21527.
44. Deckert M, Elly C, Altman A, Liu YC. Coordinated regulation of the tyrosine phosphorylation of Cbl by Fyn and Syk tyrosine kinases. J Biol Chem. 1998;273:8867-8874.
45. Sada K, Zhang J, Siraganian RP. Point mutation of a tyrosine in the linker region of Syk results in a gain of function. J Immunol. 2000;164:338-344.
46. Law DA, Nannizzi-Alaimo L, Ministri K, et al. Genetic and pharmacological analyses of Syk function in αllbβ3 signaling in platelets. Blood. 1999; 93:2645-2652.
47. Turner I, Schweighoffer I, Colucci I, Di Santo JP, Tybulewicz VL. Tyrosine kinase SYK: essential functions for immunoreceptor signalling. Immunol Today. 2000;21:148-154.